TLR3-dependent regulation of cytokines in human mesangial cells: a novel role for IP-10 and TNF-α in hepatitis C-associated glomerulonephritis

被引:20
作者
Merkle, Monika [2 ]
Ribeiro, Andrea [1 ]
Woernle, Markus [1 ]
机构
[1] Med Poliklin LMU, Munich, Germany
[2] Klinikum Traunstein, Traunstein, Germany
关键词
Toll-like receptor; TOLL-LIKE RECEPTOR-3; VIRUS-INFECTION; HUMAN KIDNEY; SERUM-LEVELS; INJURY; EXPRESSION; CHEMOKINES; THERAPY; TERM;
D O I
10.1152/ajprenal.00083.2011
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Merkle M, Ribeiro A, Wornle M. TLR3-dependent regulation of cytokines in human mesangial cells: a novel role for IP-10 and TNF-alpha in hepatitis C-associated glomerulonephritis. Am J Physiol Renal Physiol 301: F57-F69, 2011. First published March 30, 2011; doi: 10.1152/ajprenal.00083.2011.-In viral infections, disease manifestations and tissue damage often result primarily from immune cells infiltrating target organs on the basis of an ineffectual viral clearance with persistent antigenemia or an inappropriate immune response. Cell types and mediators defining these inflammatory processes are still inadequately understood. In hepatitis C virus-associated glomerulonephritis, analysis of interferon-gamma-inducible protein (IP-10) as a chemokine centrally involved in early antiviral response and TNF-alpha known to balance proinflammatory and immunosuppressive effects in inflammation shows a significant upregulation of both IP-10 and TNF-alpha mediated specifically by the viral receptor Toll-like receptor 3 expressed on mesangial cells. IP-10 induction is further potentiated by TNF-alpha signaling, preferentially via the TNF-alpha receptor subtype 2 selectively increased upon stimulation of viral receptors in the proinflammatory milieu.
引用
收藏
页码:F57 / F69
页数:13
相关论文
共 30 条
[1]   TNFR1-and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury [J].
Al-Lamki, RS ;
Wang, J ;
Vandenabeele, P ;
Bradley, JA ;
Thiru, S ;
Luo, DH ;
Min, W ;
Pober, JS ;
Bradley, JR .
FASEB JOURNAL, 2005, 19 (12) :1637-1645
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   High Values of CXCL 10 Serum Levels in Mixed Cryoglobulinemia Associated With Hepatitis C Infection [J].
Antonelli, Alessandro ;
Ferri, Clodoveo ;
Fallahi, Poupak ;
Ferrari, Silvia Martina ;
Sebastiani, Marco ;
Ferrari, Daniela ;
Giunti, Marco ;
Frascerra, Silvia ;
Tolari, Simone ;
Franzoni, Ferdinando ;
Galetta, Fablo ;
Marchi, Santino ;
Ferrannini, Ele .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (10) :2488-2494
[4]   Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients [J].
Aringer, Martin ;
Houssiau, Frederic ;
Gordon, Caroline ;
Graninger, Winfried B. ;
Voll, Reinhard E. ;
Rath, Eva ;
Steiner, Guenter ;
Smole, Josef S. .
RHEUMATOLOGY, 2009, 48 (11) :1451-1454
[5]   Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis [J].
Banas, B ;
Wörnle, M ;
Berger, T ;
Nelson, PJ ;
Cohen, CD ;
Kretzler, M ;
Pfirstinger, J ;
Mack, M ;
Lipp, M ;
Gröne, HJ ;
Schlöndorff, D .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4301-4307
[6]   Immunoregulatory role of TNFα in inflammatory kidney diseases [J].
Ernandez, Thomas ;
Mayadas, Tanya N. .
KIDNEY INTERNATIONAL, 2009, 76 (03) :262-276
[7]   Mouse hepatitis virus infection of the central nervous system: Chemokine-mediated regulation of host defense and disease [J].
Glass, WG ;
Chen, BP ;
Liu, MT ;
Lane, TE .
VIRAL IMMUNOLOGY, 2002, 15 (02) :261-272
[8]   A RAPID COLORIMETRIC ASSAY FOR THE DETERMINATION OF IL-2-PRODUCING HELPER T-CELL FREQUENCIES [J].
HEEG, K ;
REIMANN, J ;
KABELITZ, D ;
HARDT, C ;
WAGNER, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 77 (02) :237-246
[9]   TNF-α bioactivity-inhibiting therapy in ANCA-associated vasculitis:: Clinical and experimental considerations [J].
Huugen, Dennis ;
Tervaert, Jan Willem Cohen ;
Heeringa, Peter .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (05) :1100-1107
[10]   Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group [J].
Joy, Melanie S. ;
Gipson, Debbie S. ;
Powell, Leslie ;
MacHardy, Jacqueline ;
Jennette, J. Charles ;
Vento, Suzanne ;
Pan, Cynthia ;
Savin, Virginia ;
Eddy, Allison ;
Fogo, Agnes B. ;
Kopp, Jeffrey B. ;
Cattran, Daniel ;
Trachtman, Howard .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (01) :50-60